437 related articles for article (PubMed ID: 22827507)
1. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
[TBL] [Abstract][Full Text] [Related]
2. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
4. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
Benbarka MM; Khalil AB; Beshyah SA; Marjei S; Awad SA
Diabetes Technol Ther; 2010 Apr; 12(4):287-90. PubMed ID: 20210567
[TBL] [Abstract][Full Text] [Related]
5. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
[TBL] [Abstract][Full Text] [Related]
6. Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan.
Hajjaji IM; Eshwihdi N; Barrowman N
Int J Clin Pract; 2019 Jun; 73(6):e13348. PubMed ID: 30912213
[TBL] [Abstract][Full Text] [Related]
7. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education.
Ahmedani MY; Haque MS; Basit A; Fawwad A; Alvi SF
Diabet Med; 2012 Jun; 29(6):709-15. PubMed ID: 22587405
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
Elbarbary NS
Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012
[TBL] [Abstract][Full Text] [Related]
9. Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
Deeb A; Al Qahtani N; Attia S; Al Suwaidi H; Nagelkerke N
Diabetes Technol Ther; 2016 Sep; 18(9):539-42. PubMed ID: 27500913
[TBL] [Abstract][Full Text] [Related]
10. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
Kobeissy A; Zantout MS; Azar ST
Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
[TBL] [Abstract][Full Text] [Related]
11. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.
Aziz KM
Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680
[TBL] [Abstract][Full Text] [Related]
12. Insulin therapy during Ramadan fast for Type 1 diabetes patients.
Kassem HS; Zantout MS; Azar ST
J Endocrinol Invest; 2005 Oct; 28(9):802-5. PubMed ID: 16370558
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.
Hassanein M; Abdallah K; Schweizer A
Vasc Health Risk Manag; 2014; 10():319-26. PubMed ID: 24920915
[TBL] [Abstract][Full Text] [Related]
14. Safety of Ramadan fasting in young patients with type 1 diabetes: A systematic review and meta-analysis.
Loh HH; Lim LL; Loh HS; Yee A
J Diabetes Investig; 2019 Nov; 10(6):1490-1501. PubMed ID: 30938074
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA
J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037
[TBL] [Abstract][Full Text] [Related]
16. Attitude and safety of patients with diabetes observing the Ramadan fast.
Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan.
Salti I;
Diabet Med; 2009 Dec; 26(12):1255-61. PubMed ID: 20002478
[TBL] [Abstract][Full Text] [Related]
18. Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes.
Ahmedani MY; Ghafoor E
Diabetes Res Clin Pract; 2020 Jul; 165():108234. PubMed ID: 32450103
[TBL] [Abstract][Full Text] [Related]
19. Insulin therapy during Ramadan fast for patients with type 1 diabetes mellitus.
Azar ST; Khairallah WG; Merheb MT; Zantout MS; Fliti F
J Med Liban; 2008; 56(1):46. PubMed ID: 19534091
[No Abstract] [Full Text] [Related]
20. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
